Vincent Medical Holdings Limited (HKG:1612)
Hong Kong
· Delayed Price · Currency is HKD 0.850
0.00 (0.00%)
Apr 29, 2026, 3:46 PM HKT
Vincent Medical Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 932.78 | 800.96 | 717.97 | 629.24 | 777.72 | Upgrade
|
| Revenue Growth (YoY) | 16.46% | 11.56% | 14.10% | -19.09% | -32.69% | Upgrade
|
| Cost of Revenue | 605.34 | 540.97 | 477.59 | 463.89 | 518.62 | Upgrade
|
| Gross Profit | 327.44 | 259.99 | 240.39 | 165.35 | 259.1 | Upgrade
|
| Selling, General & Admin | 149.31 | 151.2 | 138 | 133.65 | 125.42 | Upgrade
|
| Research & Development | 48.74 | 30.6 | 36.06 | 36.68 | 39.25 | Upgrade
|
| Other Operating Expenses | -4.62 | -2.24 | -0.64 | -3.44 | 7.24 | Upgrade
|
| Operating Expenses | 193.44 | 182.18 | 174.51 | 166.89 | 171.9 | Upgrade
|
| Operating Income | 134.01 | 77.82 | 65.88 | -1.54 | 87.2 | Upgrade
|
| Interest Expense | -0.9 | -1.36 | -1.68 | -2.85 | -2.43 | Upgrade
|
| Interest & Investment Income | 1.3 | 1.2 | 0.7 | 0.51 | 0.38 | Upgrade
|
| Earnings From Equity Investments | 0.84 | -0.33 | 2.82 | -1.66 | -5.88 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.94 | 2.87 | 0.48 | -5.77 | 0.81 | Upgrade
|
| EBT Excluding Unusual Items | 137.2 | 80.2 | 68.2 | -11.31 | 80.08 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1 | -1.15 | -1.66 | -3.82 | -10.73 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.45 | 0.62 | -2.26 | Upgrade
|
| Asset Writedown | -6.56 | -1.07 | -0.08 | -1.01 | -0.92 | Upgrade
|
| Pretax Income | 129.64 | 77.98 | 66.92 | -15.52 | 66.18 | Upgrade
|
| Income Tax Expense | 21.29 | 7.08 | 8.71 | 2.87 | 6.11 | Upgrade
|
| Earnings From Continuing Operations | 108.35 | 70.9 | 58.21 | -18.39 | 60.07 | Upgrade
|
| Minority Interest in Earnings | -3.97 | -1.73 | -0.93 | 0.99 | 0.63 | Upgrade
|
| Net Income | 104.38 | 69.17 | 57.28 | -17.4 | 60.7 | Upgrade
|
| Net Income to Common | 104.38 | 69.17 | 57.28 | -17.4 | 60.7 | Upgrade
|
| Net Income Growth | 50.91% | 20.76% | - | - | -72.01% | Upgrade
|
| Shares Outstanding (Basic) | 645 | 643 | 646 | 654 | 654 | Upgrade
|
| Shares Outstanding (Diluted) | 645 | 643 | 646 | 654 | 661 | Upgrade
|
| Shares Change (YoY) | 0.27% | -0.36% | -1.24% | -1.12% | 1.49% | Upgrade
|
| EPS (Basic) | 0.16 | 0.11 | 0.09 | -0.03 | 0.09 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.11 | 0.09 | -0.03 | 0.09 | Upgrade
|
| EPS Growth | 50.51% | 21.20% | - | - | -72.42% | Upgrade
|
| Free Cash Flow | - | -20.98 | 93.34 | 57.16 | 94.1 | Upgrade
|
| Free Cash Flow Per Share | - | -0.03 | 0.14 | 0.09 | 0.14 | Upgrade
|
| Dividend Per Share | 0.050 | 0.033 | 0.028 | - | 0.045 | Upgrade
|
| Dividend Growth | 51.52% | 20.00% | - | - | -59.09% | Upgrade
|
| Gross Margin | 35.10% | 32.46% | 33.48% | 26.28% | 33.32% | Upgrade
|
| Operating Margin | 14.37% | 9.71% | 9.18% | -0.24% | 11.21% | Upgrade
|
| Profit Margin | 11.19% | 8.63% | 7.98% | -2.77% | 7.80% | Upgrade
|
| Free Cash Flow Margin | - | -2.62% | 13.00% | 9.09% | 12.10% | Upgrade
|
| EBITDA | 155.79 | 99.6 | 88.07 | 22.21 | 111.65 | Upgrade
|
| EBITDA Margin | 16.70% | 12.43% | 12.27% | 3.53% | 14.36% | Upgrade
|
| D&A For EBITDA | 21.78 | 21.78 | 22.19 | 23.74 | 24.44 | Upgrade
|
| EBIT | 134.01 | 77.82 | 65.88 | -1.54 | 87.2 | Upgrade
|
| EBIT Margin | 14.37% | 9.71% | 9.18% | -0.24% | 11.21% | Upgrade
|
| Effective Tax Rate | 16.42% | 9.08% | 13.01% | - | 9.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.